The BRAIN Foundation Synchrony 2021 Stream on Zoom & Facebook December 11-12 From Bench to BioPharma WATCH FOR FREE AGENDA
9:00 AM - 5:00 PM PST

December 11, 2021

9:00 AM - 9:15 AM

Pramila Srinivasan, PhD

President & Founder, The BRAIN Foundation

Opening Remarks

9:15 AM - 9:45 AM

Richard Frye, MD, PhD (chair)

Neurologist
Phoenix Children’s Hospital and University of Arizona College of Medicine-Phoenix

Update on Mitochondrial Research

9:45 AM - 10:15 AM

Edward Quadros, PhD, SUNY

Professor, Department of Cell Biology
SUNY Downstate Health Sciences University

Folates, Folate Receptor Autoantibodies and the connection to Autism Spectrum Disorders

10:15 AM - 10:45 AM

Harris Huberman, MD

Professor of Pediatrics, The Children’s Hospital
SUNY Downstate

Folate autoantibody trajectories and ASD identification in early childhood

10:45 AM - 11:00 AM

BREAK

11:00 AM - 11:30 AM

T. Atilla Ceranoglu, MD

Director, Psychiatry Service, Shriners Hospital for Children
Massachusetts Gen. Hospital, Boston, MA

Evaluation of Transcranial Photobiomodulation in Autism Spectrum Disorder: Double-Blind, Placebo-Controlled, Randomized Clinical Study of a Novel Approach

11:30 AM - 12:00 PM

Karen Parker, PhD

Associate Professor and Associate Chair, Department of Psychiatry and Behavioral Sciences
Stanford University

Vasopressin: A promising neurochemical marker and therapeutic for autism

12:00 PM - 12:30 PM

LUNCH

12:30 PM - 12:45 PM

Neil Littman

Founder & CEO, Bioverge Inc.

Democratizing Access to Early-stage Healthcare Investments

12:45 PM - 1:15 PM

John Slattery

Co-founder, President & CEO, BioROSA

Metabolic Autism Prediction (MAP) Study: A multicenter prospective double-blind case/control study assessing metabolic prediction of ASD from a developmental pediatrics waitlist

1:15 PM - 1:45 PM

Mark Smith, PhD

CEO, Finch Therapeutics

FIN-211, an investigational microbiome therapeutic in development for autism

1:45 PM - 2:15 PM

Stephen O’Quinn, PharmD

Vice President, Medical Affairs, Zynerba Pharmaceuticals

ZYN002 Cannabidiol Transdermal Gel Efficacy and Safety: Recent Clinical Research Advances in the Treatment of Autism and Fragile X Syndrome

2:15 PM - 2:45 PM

Eugene Prahin

CFO, Yamo Pharmaceuticals

L1-79 for treatment of core symptoms of autism

2:45 PM - 3:00 PM

BREAK

3:00 PM - 3:30 PM

Colleen Kraft, MD, MBA, FAAP

Senior Medical Director, Clinical Adoption, Cognoa
Professor of Pediatrics, Keck School of Medicine, University of Southern California

Streamlining the Current Autism Diagnostic Pathway

3:30 PM - 4:00 PM

Randy Blakely, PhD (CHAIR)

Executive Director
Stiles-Nicholson Brain Institute and Florida Atlantic University College of Medicine
 

Bidirectional Neuroinflammatory and Serotonin Signaling: Basic and Translational Perspectives

4:00 PM - 4:30 PM

Aurelio Galli, PhD, DSc

Director for Gastrointestinal Biology Research
University of Alabama at Birmingham

Watch Flies Teaching Us Mechanisms of Neuropsychiatric Disorders

4:30 PM - 5:00 PM

Harumi Jyonouchi, MD

Allergy and Immunology
Saint Peter’s University Hospital

Biomarkers of Innate Immune Memory in Autism Spectrum Disorders

9:00 AM - 4:15 PM PST

December 12, 2021

9:05 AM - 9:35 AM

Sarkis Mazmanian, PhD (chair)

Luis B. and Nelly Soux Professor of Microbiology
California Institute of Technology

Gene-Microbiome Interactions in an ASD Mouse Model

9:35 AM - 10:05 AM

Joseph D. Buxbaum, PhD

Professor of Psychiatry, Neuroscience, Genetics and Genomic Sciences
Icahn School of Medicine at Mount Sinai

10:05 AM - 10:35 AM

Stuart Lipton, MD, PhD

Hannah and Eugene Step Chair; Professor; Co-director, Neuroscience Translational Center Department of Molecular Medicine
The Scripps Research Institute

10:35 AM - 11:05 AM

Kazue Takahashi, PhD

Assistant Professor, Department of Radiology
Gordon Center for Medical Imaging, Harvard Medical School

Mannose Binding Lectin in Health and Diseases

11:05 AM - 11:10 AM

BREAK

11:10 AM - 11:40 AM

Paul Ashwood, PhD

Professor, Department of Medical Microbiology and Immunology
University of California, Davis

11:40 AM - 12:10 PM

Arthur Krigsman, MD

Pediatric Gastroenterologist
Private Practice, New York

Stephen Walker, PhD

Professor, Wake Forest Institute for Regenerative Medicine
Wake Forest School of Medicine

Improvement in Gastrointestinal Symptoms, Cognition and Behavior Upon Treatment of ASD- associated Enterocolitis

12:10 PM - 12:40 PM

Alessio Fasano, MD

Division Chief, Pediatric Gastroenterology and Nutrition
Director, Center for Celiac Research and Treatment
Director, Mucosal Immunology and Biology Research Center
Massachusetts General Hospital for Children

Using a Humanized Mouse Model And Human Intestinal Tissue to Evaluate the Zonulin  Pathway For Personalized Treatment of Autism Spectrum Disorder

 

12:40 PM - 1:00 PM

LUNCH

1:00 PM - 1:30 PM

Robert K. Naviaux, MD, PhD

Professor of Genetics
Biochemical Genetics and Metabolism
Departments of Medicine, Pediatrics, and Pathology
Co-director, The Mitochondrial and Metabolic Disease Center (MMDC)
UCSD School of Medicine

Emerging therapeutics for ASD—shifting paradigms and improving outcomes with mitochondrial cell danger response  (CDR) and healing cycle research

1:30 PM - 2:00 PM

Community Questions to Researchers (Panel)

2:00 PM - 2:15 PM

Uli Chettipally, MD, MPH

CEO, Sirica Therapeutics

Sirica Therapeutics – Making Therapy Fun!

2:15 PM - 2:45 PM

Stewart Campbell, PhD (CHAIR)

CEO, Axial Biotherapeutics

Targeting bacterial metabolites as a strategy to manage irritability associated with autism

2:45 PM - 3:15 PM

James N. Woody, MD, PhD

CEO, MARAbiosystems

MaraBio, A Precision Medicine ASD Diagnostic Company

3:15 PM - 3:45 PM

Erik Won

President & CMO, Wave Neuro

Biometric-Guided TMS for Kleefstra Syndrome

3:45 PM - 4:15 PM

Eugenia Steingold, PhD

Chief Science Officer, JelikaLite Corp. 

Transcranial Photobiomodulation (tPBM) May Reduce Symptoms of Autism in Children: a Randomized, Double-Blind, Placebo-Controlled, Randomized Study